| Label | Description |
|
|---|---|---|---|
A Knowledge Graph Assertion from Metabolomics | |||
(8S,9S,10R,11S,13R,14S,17S)-11-hydroxy-17-(2-hydroxyacetyl)-10-methyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-13-carbaldehyde correlated with condition ADRENAL INSUFFICIENCY, CONGENITAL, WITH 46,XY SEX REVERSAL, PARTIAL OR COMPLETE Knowledge Graph Assertion (Entity type) | A Knowledge Graph Assertion from Metabolomics | ||
A Knowledge Graph Assertion from Metabolomics | |||
A Knowledge Graph Assertion from Metabolomics | |||
A Knowledge Graph Assertion from Metabolomics | |||
A Knowledge Graph Assertion from Metabolomics | |||
A Knowledge Graph Assertion from Metabolomics | |||
A Knowledge Graph Assertion from Metabolomics | |||
A Knowledge Graph Assertion from Metabolomics | |||
A Knowledge Graph Assertion from Metabolomics |
A Knowledge Graph Assertion from Metabolomics
(8S,9S,10R,11S,13R,14S,17S)-11-hydroxy-17-(2-hydroxyacetyl)-10-methyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-13-carbaldehyde correlated with condition ADRENAL INSUFFICIENCY, CONGENITAL, WITH 46,XY SEX REVERSAL, PARTIAL OR COMPLETE
Knowledge Graph Assertion (Entity type)A Knowledge Graph Assertion from Metabolomics
A Knowledge Graph Assertion from Metabolomics
A Knowledge Graph Assertion from Metabolomics
A Knowledge Graph Assertion from Metabolomics
A Knowledge Graph Assertion from Metabolomics
A Knowledge Graph Assertion from Metabolomics
A Knowledge Graph Assertion from Metabolomics
A Knowledge Graph Assertion from Metabolomics
A Knowledge Graph Assertion from Metabolomics